Laddar...
Two roads for oncolytic immunotherapy development
Oncolytic viruses are an emerging class of immunotherapy agents for cancer treatment. In this issue of JITC, Machiels et al. reports early phase data from an oncolytic adenovirus given by intravenous (IV) administration. While this may allow easy access to metastatic lesions, there is limited data s...
Sparad:
| I publikationen: | J Immunother Cancer |
|---|---|
| Huvudupphovsmän: | , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
BioMed Central
2019
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6359832/ https://ncbi.nlm.nih.gov/pubmed/30709365 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40425-019-0515-2 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|